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ABSTRACT
Introduction: The number of patients with poor glycaemic control who refuse insulin therapy is alarming. Factors 
that contribute to insulin refusal are important to study to identify high risk groups so that appropriate measures can 
be taken to prevent progression of uncontrolled diabetes. The objective of this study is to determine the risk factors 
of insulin refusal among type 2 diabetes mellitus patients with poor glycaemic control at Tanglin Health Clinic, 
Kuala Lumpur, Malaysia. Methods: A case control study was conducted among 216 cases and 230 controls using 
stratified sampling method. Cases were defined as patients with HbA1C more than 7.5% but not on insulin therapy 
despite being offered by the doctor whereas controls consist of patients with HbA1C of more than 7.5% but already 
on insulin therapy.  Data was collected from April until May 2018, using a self-administered questionnaire. Analysis 
was done via IBM SPSS version 23.0. Results:  Response rate for cases was 93.9% and response rate for controls was 
100%. Risk factors of insulin refusal among poor glycaemic control includes age above 60 years old, tertiary level 
education, duration of diabetes less than 10 years, poor level of knowledge on insulin, fear on injection pain and 
fear to bruising due to injections. Conclusion: Hence, efforts must be taken to tackle the modifiable factors such as 
knowledge on insulin and diabetes, and fear on injections and bruises. 
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INTRODUCTION
Diabetes mellitus (DM) is a chronic disease characterized 
by hyperglycaemia as a result from the abnormalities in 
insulin secretion, insulin action, or both. The prevalence 
of diabetes was 6.4% affecting 285 million adults in 
2010 and was projected to rise to 7.7%, and 439 million 
adults by 2030 globally (1).  
In Malaysia, the prevalence of diabetes among adults in 
Malaysia is estimated to rise to 21.6% by the year 2020 
(2). A study in Malaysia concluded that diabetes is a 
major public health problem with prevalence of T2DM 
is 20.8% affecting 2.8 million people (3). In Malaysia, the 
prevalence among the elderly is higher than the younger 
generation and it was reported that the prevalence of 
diabetes between the age 60-64 was 26.2% compared 
to the prevalence between age group 18-19 which was 
only 2.0% (4). According to the Third National Health 
and Morbidity Survey (NHMS III) of those with diabetes, 
it was reported 73.5% seek treatment from government 
healthcare facilities and 20% from private healthcare 
facilities. At the time of survey in 2006, oral anti-
diabetic medications were given to 77% patients and 
only 7% received insulin therapy. However, there is an 
increase to 25.1% in those who received insulin therapy 
as reported in NHMS V (4). Among the known diabetics, 
25.1% were on insulin therapy and 79.1 % claimed to 
be on oral anti-diabetic drugs (2).
 A study in Johor reported the prevalence of HbA1C more 
than 6.5% was 68% with the mean of HbA1C detected 
at 7.8% (5). It was reported that poor glycaemic control 
could lead to high prevalence of micro-and macrovascular 
complications, such as neuropathy (19%), albuminuria 
(15.7%), retinopathy (11.1%), and microalbuminuria 
6.6% (6). The management of diabetes involves lifestyle 
modifications, pharmacotherapy such as OADs and 
insulin and health education for patients to encourage 
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self-efficacy and empowerment (7). Glycaemic control 
is one of the parameter of target control of T2DM and 
it includes FBG level between 4.4 to 7.0 mmol/L, post-
prandial blood glucose level between 4.4 to 8.5 mmol/L 
and HbA1C ≤ 6.5 %. The treatment algorithm for T2DM 
varies depending on both HbA1C and FBG levels (7).
Insulin is indicated for patients with poor glycaemic 
control and also to prevent complications (8). Insulin is 
often indicated for the management of poor glycaemic 
control of HbA1c ranging from 7.5% to 8.5% in 
combination with OADs to delay the development 
of microvascular and macrovascular complications 
(2). Triple combination therapy includes any three 
combinations of OAD and insulin for patients with 
HbA1C 8.5% to 10%. In patients with HbA1C > 10%, 
combination therapy coupled with basal/premixed 
insulin therapy is recommended. 
Insulin refusal is defined as an act of unwillingness to 
accept insulin (9). In today’s world, healthcare providers 
face great challenge in introducing or commencing 
insulin among type 2 diabetes mellitus (T2DM) patients 
(10). Insulin is indicated in diabetic patients, either based 
on symptoms such as severe hyperglycaemia leading 
to signs of diabetic ketoacidosis regardless of glycated 
hemoglobin (HbA1C) and fasting blood glucose (FBG) 
and in T2DM patient on maximal oral anti-diabetic 
(OADS) with HbA1C more than 7.0% (2).
The recent National Diabetes Registry Report 2016 
showed the distribution of diabetes patients with HbA1C 
more than 8.0% in health clinics in Federal Territory of 
Kuala Lumpur was 32.81% and only 25.1% patients 
had HbA1C less than 6.5 % (11). Hence, it shows high 
percentage of poor glycaemic control among active 
and registered diabetic patients in the Federal Territory 
of Kuala Lumpur. The recent audit from 720 patients 
selected from National Diabetes Registry showed only 
33.33% was on insulin therapy at Tanglin Health 
Clinic, Kuala Lumpur. A cross-sectional study done at 
13 health clinics in Johor revealed 68% of patients with 
T2DM has poor glycaemic control but only  63.8% 
patients received insulin therapy alone  and 58.3% on 
combination therapy of insulin and oral hypoglycemic 
agents (5). The objective of this study is to identify the 
risk factors of insulin refusal among T2DM patients 
(among the cases and controls ) at the Tanglin Health 
Clinic, Kuala Lumpur. 
 
MATERIALS AND METHODS
Study location, study design, sampling methods and 
variables
This study was conducted in Tanglin Health Clinic which 
is located in the Federal Territory of Kuala Lumpur. The 
design of study is case control. The study design is guided 
by the Strengthening the Reporting of Observational 
Studies in Epidemiological (STROBE) statement (12). 
The study was conducted from September 2017 to July 
2018, while the data was collected from April until May 
2018.The study population consists of T2DM patients 
with poor glycaemic control of more than 7.5% HbA1C 
in Tanglin Health Clinic in Kuala Lumpur. On average, 
60 -80 patients come for follow up sessions at this clinic 
on a daily basis at this clinic daily from Monday till 
Thursday. 
Stratified sampling method was employed based on 
insulin used status as a stratum. The sampling frame 
for cases were obtained from the list of T2DM patients 
who were indicated and offered for insulin but refused 
and controls consists of list of T2DM patients who were 
already on insulin. Cases were patients with HbA1C 
more than 7.5% but not on insulin therapy despite 
being offered by the doctor and control group consists 
of patients with HbA1C more than 7.5% but already on 
insulin therapy. First, patients with history of HbA1C 
more than 7.5% from the green book were selected 
based on colour coding from their NCD follow up record 
book. Next, individual’s status on insulin usage were 
identified from the case notes and computer records. 
Then, stratification by their insulin status into insulin 
users and insulin refusal was conducted. From each 
strata, simple random sampling was done from both 
stratum (cases) and (controls) lists of patients attending 
the scheduled consultations. Their nearest appointment 
dates were identified and questionnaires was given 
to them on their consultation days. For this study, the 
sample size was calculated by using two proportion 
formula for case control study which is 230 for cases 
and 230 for controls (13). 
Instruments
The study instrument used were questionnaire 
and patient’s NCD record book. There are 5 main 
sections which are, section A on socio-demographic 
characteristics, section B on diabetes knowledge, 
section C on diabetes stigma, section D on physical 
factor (fear on injection and bruises), section E on social 
support. The questionnaire was adapted from validated 
instruments with permission granted from respective 
authors. This questionnaire was designed to facilitate 
the purpose of this study which is to identify the risk 
factors of insulin refusal among Type 2 Diabetes Mellitus 
patients with poor glycaemic control. The patients’ NCD 
record books were used to trace the latest HbA1C level 
recorded in the book.
Section A: Socio-demographic Characteristics
This section contains socio-demographic characteristics 
including age, gender, ethnicity, marital status, 
education level, duration of diabetes and income level.
Section B: Diabetes Knowledge
The questions from this section were adapted from the 
Revised Diabetes Knowledge Test (DKT) instrument 
(14). There are 4 statements chosen from this instrument, 
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with 4 other statements were added accordingly. All 
were true statements. Respondents were asked to circle 
round either ‘true’, or ‘false’ or ‘don’t know’. Scoring 
system includes 1 mark for correct statement and 0 mark 
for wrong statement. Then total sum of scores were 
calculated (14).
Section C: Diabetic Related Stigma
This part of questionnaire assessed the diabetic related 
stigma such as insulin related stigma and social stigma 
on insulin therapy. The instrument used is Diabetic 
Stigma Assessment Scale (DSAS-2).15 A total of 17 items 
were included and scores given based on 5 points Likert 
Scale, 1 point for strongly disagree, 2 points for disagree, 
3 points for unsure, 4 points for agree and 5 points for 
strongly agree. 
The DAS-2 has 3 subscales which are, ‘Treated 
Differently’ were calculated by summing item scores on 
items 1,4,7,10,14,17 with possible range: 6-30 ‘Blame 
and judgement’ calculated by summing item scores on 
items 2,3,8,12,16  possible range will be 6-30 and ‘self-
stigma’ calculated by summing items scores on items 
5,6, 9,11,13,15  with possible score range of 5-25 (15). 
The score was then categorized into low and high based 
on the formula [(maximum-minimum)/2] + minimum 
score.
Section D: Physical factor
In this section, no available instrument, thus patients 
were asked regarding their fear on injections of insulin 
and fear on bruising at injection site. They were asked to 
answer whether yes or no.
Section E: Social Support
In this section, questions on various dimension of social 
support were adapted and adopted from the Social 
Support Survey Medical Outcomes Study (SS) which 
consists of 11 items, item 1 will enquire about number 
of close friends and relatives whom ones feel at ease 
with and the other 10 items measures emotional support/
informational support (items 3, 4, 8, 13, 16, 19) and 
tangible support (items 2, 5, 12, 15). The score ranges 
from 1 to 5. Minimum score will be 1 and maximum 
score will be 50. A higher score indicates better social 
support. The score was then categorized into low and 
high based on the formula [(maximum-minimum)/2] + 
minimum score. Permission to use the instrument was 
obtained from the author (16). 
Quality Control of study instrument
Face Validity
Face validity was based on the test at face value that 
was done among 25 patients from Tanglin Health Clinic 
Kuala Lumpur, who was not included in the study.  High 
face validity showed more subjects were motivated 
to answer the questions. Some of the questions was 
modified and rephrased accordingly. 
Content validity
The questionnaire was discussed with three experts in 
field of Public Health. Their comments were taken into 
considerations and corrections made accordingly. The 
corrections included on rephrasing and modifying the 
questions. Back to back translations done by the expert 
who has the Teaching English as Second Language 
(TESL) degree.
Reliability
Pre-test was done on 5 respondents per items on the 
largest instrument which is Diabetes Attitude Scale 
and was 85 respondents. To achieve good internal 
consistency before the actual study begins, this test was 
conducted on the 85 patients who were in the sampling 
population but not in the sampling frame. They were 
T2DM patients from Tanglin Health Clinic, Kuala 
Lumpur. Cronbach’s Alpha was analysed using SPSS for 
internal consistency reliability. Cronbach’s Alpha for all 
4 sections with its domains reported in Table I.
Table I: Reliability Test Results
Section Domain Cronbach’s Alpha
Knowledge on Insulin 0.645
Diabetes Stigma As-
sessment Scale
Treated Differently 0.725
Blame and Judgement 0.791
Self-stigma 0.858
Physical Factors 0.878
Social Support
Emotional Support 0.887
Tangible Support 0.818
Ethical Approval
The study was registered first with National Medical 
Research Register. Ethical approval from the Medical 
Research and Ethics Committee Ministry of Health 
Malaysia, was obtained prior to data collection. 
Permission was obtained from State Health Department 
of Wilayah Persekutuan Kuala Lumpur and District 
Health Office in Wilayah Persekutuan Kuala Lumpur 
to conduct research at Tanglin Health Clinic. Informed 
consent from each respondent was included in the 
questionnaire in the Patient Information.
Analysis
Information from the questionnaire was entered into 
data file using statistical package of, IBM SPSS Statistics 
Version 23.0. Before data analysis, screening for any error 
or out of range error was done few times. Data analysis 
comprising descriptive, univariable and multivariable 
analysis were done. Descriptive statistics   described 
characteristics of the respondent and assumptions on 
normality checked. Data transformation was made from 
continuous to categorical. Continuous variables that are 
normally distributed described as mean and standard 
deviations (SD). Chi Square test was used to measure 
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associations between two categorical variables. Simple 
logistic regression was done to determine the association 
between the continuous independent and categorical 
dependent data. Multiple logistic regression was used 
to determine the risk factors of insulin refusal among the 
T2DM patients with poor glycaemic control.
RESULTS
The response rate for control was 100%, and the 
response rate for cases was 93.9%. Altogether 3 patients 
were excluded in the final data analysis because of 
missing information on duration of diabetes. Therefore, 
the total number of patients which included in this study 
was 446.
Characteristics of Respondents
Socio-demographic Characteristics and Diabetic Profile
Majority of the study subjects were aged 60 years old 
and above (n = 238, 53.4%) especially among cases 
(55.6%). Majority of study subjects were females 
(58.1%) and Malays (74.7%). There is a significant 
difference in the distribution of ethnicity between cases 
and controls (Fisher’= 8.79, p = 0.027). Most of the study 
subjects were married (76.0%). Half of the recruited 
study subjects have secondary education (50.0%) while 
29.6% have primary and lower education, followed by 
20.4% with tertiary education. The proportion of cases 
with tertiary education was significantly higher among 
cases compared to controls (26.4% vs. 14.8%; χ2 = 
12.43, p = 0.006*). The proportion of insulin refusal was 
significantly higher among those who were diagnosed 
with diabetes less than 10 years (61.9% vs. 36.8%; χ2 = 
10.93, p <0.001) (Table II).
Knowledge on Insulin
A significantly higher proportion of cases have poor 
level of knowledge on insulin compared to controls 
(44.4% vs. 14.8%; χ2 = 50.62, p <0.001) (Table II).
Diabetes Related Stigma
Most of study population have low diabetes stigma. 
There is no significant distribution was observed 
between cases and controls (Table II).
Physical Factors of Insulin Injection
Table II shows that majority of the study subjects were 
not fear of pain when injecting insulin (58.5%). Similarly, 
majority of study subjects were not fear of bruising due 
to injection (60.1%). However, a significantly higher 
proportion of cases be afraid of pain and bruises due to 
injection compared to controls (72.7% vs. 12.2%; χ2 = 
168.03, p <0.001 and 67.6% vs. 13.9%; χ2 = 133.84, p 
<0.001 respectively) (Table II).
Social Support
Majority of the study subjects have high level of tangible 
support (61.9%); however, a higher proportion of cases 
Table II: Distribution of study subjects by socio-demographic charac-
teristic, knowledge, physical factor, diabetes stigma and social sup-
port.
Characteristics (n = 446)
Case Control χ2
p-value
n (%) n (%)
Age
< 50 22 (10.2) 37 (16.1) 3.40 0.183
50 – 59 74 (34.2) 75 (32.6)
≥ 60 120(55.6) 118(51.3)
Gender
Male 94 (43.5) 93 (40.4) 0.435 0.510
Female 122(56.5) 137(59.6)
Ethnicity 
Malay 149(69.0) 184(80.0) 8.79b 0.027*
Chinese 22 (10.2) 10 (4.3)
Indian 42 (19.4) 34 (14.8)
Others 3 (1.4) 2 (0.9)
Marital status
Single 11 (5.1) 6 (2.6) 1.93 0.381
Married 161(74.5) 178(77.4)
Widowed 44 (20.4) 46 (20.0)
Educational level
Primary education and lower 51(23.6) 81 (35.2) 12.424 0.002*
Secondary education 108(50.0) 115(50.0)
Tertiary education 57 (26.4) 34 (14.8)
Duration of Diabetes
 (n = 443)a
< 10 years 133(61.9) 84 (36.8) 10.93 <0.001*
≥ 10 years 82 (38.1) 144(63.2) <0.001*
Level of knowledge
Poor 96 (44.4) 34 (14.8) 50.62 <0.001*
Moderate 66 (30.6) 87 (37.8)
Good 54 (25.0) 109 (47.4)
Treated Differently
Low 203 (94.0) 206 (89.6) 2.86 0.091
High 13 (6.0 24 (10.4)
Blame and judgement
Low 147 (68.1) 151 (65.7) 0.29 0.590
High 69 (31.9) 79 (34.3)
Self-stigma
Low 173 (80.1) 190 (82.6) 0.47 0.495
High 43 (19.9) 40 (17.4) 0.47 0.495
Fear of injection
pain
Yes 157(72.7) 28(12.2) 168.3 <0.001
No 59(27.3) 202(87.8)
Fear of bruises due to 
injection pain
Yes 146(67.6) 32(13.9) 133.84 <0.001
No 70(32.4) 198(86.1)
Tangible support
Low 90 (41.7) 80(34.8) 2.24 0.135
High 126 (58.3) 150(65.2)
Emotional/informational 
support 
Low 26 (12.0) 32 (13.9) 0.35   0.556
High 190 (88.0) 198(86.1)
Note: (a) = 3 missing, (b) Fisher’s Exact Test
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have low tangible support compared to controls (41.7% 
vs. 34.8%). A higher proportion of cases have high 
emotional or informational support (88.0% vs. 86.1%). 
However, no significant difference was observed 
between cases and controls (Table II).
Crude Odds Ratio Associated with Insulin Refusal 
among Type II Diabetes Patients
This section presents the statistical results of association 
between socio-demographic characteristics, diabetic 
profile, knowledge on insulin, diabetes stigma, 
physical factor of injection, social support and insulin 
refusal among type II diabetes patients. Simple logistic 
regression was performed to determine the association 
between independent and dependent data. It is also 
carried out in order to screen for the most important 
variables to be entered into multivariate analysis model 
to further determine the risk factors for insulin refusal.
Association between Socio-Demographic 
Characteristics, Diabetes Profile and Insulin Refusal 
among Type II Diabetes Patients
Patients with tertiary education background found 
to increase insulin refusal more than 2.5 times higher 
(COR = 2.59, 95% CI = 1.09, 6.18) compared to those 
with lower education level. Higher duration of diabetes 
was associated with lower insulin refusal (COR = 0.89, 
95% CI = 0.87, 0.93). Consistently, patients diagnosed 
with diabetes less than 10 years had increased chance of 
insulin refusal by more than two-fold (AOR = 2.78, 95% 
CI = 1.89, 4.09). 
Association between Knowledge on Insulin and Insulin 
Refusal among Type II Diabetes Patients
Poor level of knowledge increases insulin refusal more 
than five times (COR = 5.70, 95% CI = 3.41, 9,48) 
(Table III).
Association between Physical Factors and Insulin 
Refusal among Type II Diabetes Patients
Physical factor such as fear to pain of insulin injections 
significantly increases the insulin refusal more than 19 
times (COR = 19.19, 95% CI = 11.69, 31.51) while fear 
to bruises due to insulin injections are almost 13 times 
likely to refuse insulin (COR = 12.9, 95% CI = 8.07, 
20.54) (Table III).
Risk Factors of Insulin Refusal
Based on simple logistic regression, variables were 
selected as the most important variables to be entered 
into the model based on selection criteria with p < 0.05 
for 6 variables. However, 2 variable not significant 
with p value less than 0.25 were also included in the 
model because according to Hosmer and Lemmeshow 
recommended this p value when it was discovered that 
the use of the p <0.05 used initially often fails to identify 
some variables that shows significance importance (17). 
Therefore, 8 variables from univariable analysis were 
Table III: Association between socio-demographic characteristics, 
diabetes profile, knowledge on insulin and diabetes, diabetes stigma, 
physical factor and social support with insulin refusal among type II 
diabetes patients
 Characteristics (n = 466) COR 95% CI p- value
Age at recruitment (years)
< 50 1.00
50 – 59 1.66 0.90 – 3.08 0.108
≥ 60 1.71 0.95 – 3.07 0.072
Gender
Male 1.14 0.78 – 1.65 0.510
Female 1.00
Ethnicity 
Malay 0.54 0.09 – 3.27 0.503
Chinese 1.47 0.21 – 10.2 0.699
Indian 0.82 0.13 – 5.21 0.837
Marital status
Single 1.92 0.65 – 5.63 0.236
Married 0.95 0.59 – 1.51 0.814
Widowed 1.00
Educational level
Primary and lower education 1.00
Secondary education 1.92 0.96 – 2.31  0.074
Tertiary education 2.66 1.54 – 4.62 <0.001*
Duration of Diabetes (years)
< 10 years 2.78 1.89 – 4.09 < 0.001*
≥ 10 years 1.00
Level of knowledge
Poor 5.70 3.43 – 9.49 < 0.001*
Moderate 1.53 0.97 – 2.42 0.068
Good 1.00
Treated Differently
Low 1.00
High 0.55 0.27 – 1.11 0.949
Blame and Judgement
Low 1.00
High 0.90 0.61 – 1.33 0.590
Self-stigma
Low 1.00
High 1.18 0.73 – 1.90 0.495
Fear of pain when injecting insulin
Yes 19.2 11.7 – 31.5 < 0.001*
No 1.00
Fear of bruising due to injection
Yes 12.9 8.07 – 20.6 <0.001*
No 1.00
No of people to support
0-5 1.14 0.54-2.43 0.73
6-10 0.94 0.42-2.09 0.88
11 and above 1.00
Tangible support
Low 1.34 0.91 – 1.97 0.135
High 1.00
Emotional/informational support
Low 0.85 0.49 – 1.47 0.556
High 1.00
(*) – Significant at p <0.05
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entered in multivariable analysis using the Enter method 
to obtain the p value and adjusted odds ratio with their 
95% CI. In accessing the goodness fit of the model, the 
Hosmer-Lemmeshow test conducted showed that there 
was no significant difference (p = 0. 508) between the 
observed probability and the expected probability. Only 
a very small discrepancy existed between the observed 
and the expected probability which indicates that the 
model fits. The classification table showed that the 
overall percentage correct was good 82.8%. To access 
the model discrimination, the area under the ROC curve 
was determined. The area under the ROC curve (Figure 
4.2) was 0.904, 95% CI = 0.876, 0.932), p < 0.001. This 
shows that the model discriminates 90.4% of the cases. 
The Nagelkerke R2 value was 0.605. This indicates that 
60.5% of the variation in insulin refusal explained by 
the logistic model.
Table IV shows that older patients (above 60 years 
old) increases the chance of insulin refusal by more 
than three folds (AOR = 3.93, 95% CI = 1.55, 9.97), 
compared to younger patients. Patients with tertiary 
level education were found significantly to have higher 
tendency of insulin refusal (eleven times) (AOR = 11.23, 
95% CI = 4.71, 26.89) compared to those who have 
lower education background. Duration of diabetes lower 
than 10 years was significantly associated with insulin 
refusal (AOR = 3.48, 95% CI = 1.94, 6.25). Patients with 
poor insulin knowledge tend to refuse insulin by six 
times (AOR = 6.54, 95% CI = 3.21, 13.29). Fear to pain 
during insulin injections shows significant association 
with insulin refusal of more than 12 times (AOR = 12.26, 
95% CI = 5.18, 29.00). Similarly, fear to bruising due 
to insulin injections shows significant association with 
insulin refusal by almost three times (AOR = 2.44, 95% 
CI = 1.04, 5.76). 
DISCUSSION
Age (i.e. above 60 years old), higher education level, 
duration of diabetes less than 10 years, having poor 
knowledge on insulin, fear on injection pain and fear 
on injection bruises are the factors that lead to insulin 
refusal among diabetes patients attending Tanglin 
Health Clinic, Kuala Lumpur.
This study shows that older patients (above 60 years 
old) have three times higher odds of insulin refusal 
compared to younger patients. In Tanglin Health Clinic 
Kuala Lumpur, majority of the patients who attend the 
diabetic clinic are pensioners. The reasoning for insulin 
refusal among the elderly aged group could be due to 
lack of exposure on health promotion and education on 
diabetes when they were diagnosed with diabetes. This 
is supported with the fact of our National Strategic Plan 
for Non-Communicable Disease 2010 which targeted 
and focused health promotion on the younger aged 
groups via strategic health promotion and education on 
non-communicable diseases in Malaysia (19). Thus, they 
Table IV: Multiple logistic regression analysis on risk factors of insulin 
refusal    among poorly controlled type 2 diabetes mellitus patients in 
Tanglin Health Clinic, Kuala Lumpur
Variables B SE AOR 95%CI p-value
Age at recruitment
<50 1.00
50 -59 0.83 0.47 2.29 0.92 – 
5.73
0.076
≥ 60 1.37 0.47 3.93 1.55 – 
9.97
0.004*
Marital status
Single -0.51 0.38 0.60 0.28-
1.27
0.184
Married -0.65 0.73 0.52 0.12-
2.19
0.376
Widowed 1.00
Education level
Primary and low-
er education 1.00
Secondary 1.26 0.37 3.53 1.72 – 
7.24 
<0.001*
Tertiary 2.42 0.44 11.26 4.71 
–26.89
<0.001*
Duration of diabetes (years)
< 10 years
1.25 0.30 3.48 1.94 – 
6.25
< 
0.001*
≥ 10 years 1.00
Level of knowledge
Poor 1.88 0.36 6.54 3.22 
–13.30
<0.001*
Moderate 0.64 0.33 1.90 0.99 – 
3.62
 0.053
Good 1.00
Physical Factor
Fear to pain when 
injecting insulin
Yes 2.51 0.44 12.26 5.18 
–29.00
<0.001*
No 1.00
Fear of bruising due to injection
Yes
0.89 0.44
2.44 1.04 – 
5.76
 0.041*
No 1.00
(*) – Significant at p <0.05
lack in enthusiasm to accept insulin therapy. Similarly, 
a study conducted in Iran reported age is significantly 
associated with insulin refusal. It shows older patients 
have more tendency to refuse insulin as they perceive 
taking insulin makes life more complicated (20).
Education level showed significant association with 
insulin refusal. Patients with tertiary level education had 
eleven times higher odds of insulin refusal compared to 
those who have lower education background. Having a 
tertiary education not necessarily influence the patients 
to accept insulin as they behaviour and perceptions on 
insulin therapy influences their willingness to accept 
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insulin therapy. It may be explained by their over-
confidence in their diabetes management and lack of 
time as most of these group prefers oral medications 
than insulin therapy.  Most of the respondents with 
tertiary education background are working professionals 
and may have limited time to administer insulin at 
workplace or find it a hassle to administer insulin at their 
workplace.
 
Another possible factor that could contribute to refusal 
of insulin therapy among the patients with higher 
education level could be fear and misconception 
on long-term complications of insulin therapy (9). In 
contrast, this finding differs from many other studies. 
The study done in Singapore on perceptions of insulin 
therapy amongst Asian patients with diabetes reported 
tertiary education background was associated with a 
greater willingness to accept insulin (20). Similarly, 
another study in Singapore reported that patients with 
higher educational background were willing to accept 
insulin therapy (21). Tan et al reported that 55.0% 
patients were less likely to refuse insulin therapy have 
secondary education level and above (10).  In both these 
studies, perceptions on insulin therapy plays important 
part in patients with higher education level and thus 
were more receptive in accepting insulin therapy 
(10,20).  Nur Azmiah et al reported that there was no 
association between education level and insulin refusal 
(22). However, in this present study, having a tertiary 
education background may not be sufficient enough for 
accepting insulin therapy because these patients maybe 
lacking in knowledge pertaining on insulin usage and 
benefits. 
The proportion of insulin refusal was significantly higher 
among those who were diagnosed with diabetes less than 
10 years among the cases and control (61.9% vs. 36.8%; 
respectively). This could be due to the worsen glycaemic 
control among controls compared to the cases and thus 
in need of insulin therapy earlier. Duration of having 
diabetes less than 10 years significantly associated with 
insulin refusal. Patients who have diabetes less than 10 
years are three times more likely to refuse insulin. A 
study in Kubang Pasu reported increase in one year of 
duration of T2DM reduces insulin refusal by 9.0% (10). 
Another study in Iran reported that duration of diabetes 
is significantly associated with unwillingness towards 
insulin therapy (19). The possible explanation could 
be longer time is needed for patients to understand 
the benefits of insulin. Thus, with proper exposure to 
counseling and health education on diabetes and insulin 
from time to time, patients could eventually have higher 
tendency to accept insulin therapy.
This study reported higher proportion of cases has poor 
level of knowledge on insulin compared to controls 
(44.4% vs.14.8%). Higher total score knowledge was 
associated with lower insulin refusal. This study shows 
poor level of knowledge increases insulin refusal. 
Patients with poor level of knowledge had six times 
higher odds of insulin refusal compared to patients with 
good level of knowledge. The reason behind this could 
be poor understanding on the benefits of insulin. This is 
explained by many qualitative and descriptive studies 
done worldwide.  It is similar to the findings of a study 
in Torres Island whereby poor knowledge on insulin 
was found as the main contributing factor to the barriers 
of insulin therapy among type 2 diabetes patients with 
poor glycaemic control (23). 
A study in Turkey revealed lack of knowledge on insulin 
such as benefits of insulin and mechanisms of actions 
of insulin contribute to unwillingness to take insulin 
(24). Lack of knowledge on insulin and its effectiveness 
maybe due to lack of effective communication between 
T2DM patients and the attending physicians (25). In 
Malaysian primary care, Hassan et al reported patient’s 
concern on insulin is very much influenced by their 
knowledge on insulin. When they lack in knowledge 
on how to overcome hypoglycaemia attacks, they are 
prone to refuse insulin when offered insulin therapy by 
their doctors (26).
In generally, insulin injections can be perceived as 
painful. In this study, physical factor such as fear on 
insulin injections has the highest odds of insulin refusal 
among T2DM patients.  Patients who fear injection pain 
refusal insulin by twelve times. Patients are reluctant to 
accept insulin therapy despite poor glycaemic control 
due to their biggest fear which is fear to injections. 
Some may have perception that taking insulin could 
be life-long therapy. Patients avoid insulin injection 
due to the anxiety and the concern on being injected 
on daily basis for the rest of their life (27). Thus, they 
prefer oral medications even after being counselled by 
their doctors for insulin therapy. Similar findings were 
reported in Singapore whereby fear of injections thought 
to be the most important barrier to accept insulin therapy 
(p <0.001) (Wong et al, 2010). Many other studies have 
reported that the main contributing factor for insulin 
refusal is fear to injection pain (28,29).
In contrast to these studies, a prospective study done by 
Larkin et al reported that fear towards insulin injections 
is not the most important barrier to insulin therapy. This 
is due to other psychological insulin resistance factors 
such as negative attitudes towards hypoglycaemia 
effects and perception that insulin is needed life-long 
(30). As a conclusion, all these explains why the T2DM 
patients with poorly controlled diabetes see insulin 
therapy as the last resort. Hence, specific interventions 
can be carried out to overcome the fear of insulin 
injections among diabetes patients. This could be done 
by demonstration of injecting insulin on dummies or 
let the patients experience the injections using clear 
water with the insulin pen by doctors, pharmacists and 
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diabetic nurse at healthcare facilities.
Patients who fear of bruises have almost three times 
have higher odds of insulin refusal. Females generally 
fear pain towards bruises caused by injections and thus 
reluctant to accept insulin therapy (31). 
The strength of this study was this is the first case control 
study done in Malaysia on insulin refusal among poorly 
controlled diabetes in primary care health settings. 
However, due to time constraint, the subjets of both 
cases and control could not be match.  A matching case 
control study would have been a better study and should 
be done in future study.
CONCLUSION
High risk factors include age above 60 years old, 
duration of having diabetes less than 10 years, poor 
level of knowledge on diabetes and insulin, tertiary 
education level and physical factor (fear of injection 
pain and bruises).
Health education to enhance the knowledge on benefits 
of insulin is important to increase the acceptance of 
insulin therapy among poorly controlled diabetes. 
Educational materials should be catered in multiple 
forms to ensure better understanding on insulin among 
the target group. Thus, health education and promotion 
on insulin therapy must be done collectively by regular 
counselling by doctors, diabetic nurses and pharmacists. 
Apart from that, using insulin dummy injections with 
water can be performed with the consent from patients 
who fear injection pain.
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